Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We screened a panel of already approved drugs in a cell culture model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and identified two new agents having higher antiviral potentials than the drug cand...

Full description

Bibliographic Details
Main Authors:	Ohashi, H, Watashi, K, Saso, W, Shionoya, K, Iwanami, S, Hirokawa, T, Shirai, T, Kanaya, S, Ito, Y, Kim, KS, Nomura, T, Suzuki, T, Nishioka, K, Ando, S, Ejima, K, Koizumi, Y, Tanaka, T, Aoki, S, Kuramochi, K, Hashiguchi, T, Maenaka, K, Matano, T, Muramatsu, M, Saijo, M, Aihara, K, Iwami, S, Takeda, M, McKeating, JA, Wakita, T
Format:	Journal article
Language:	English
Published:	Cell Press 2021

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Similar Items